University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

Title: Currently Approved LMWH for Treatment of PE

Category: Vascular

Keywords: LMWH, PE, Pulmonary Embolism (PubMed Search)

Posted: 8/11/2008 by Rob Rogers, MD (Updated: 7/21/2026)

Currently Approved LMWHs for the Treatment of Acute PE:

  • Enoxaparin-1 mg/kg every 12 hours subcut
  • Tinzaparin 175 Units/kg once daily subcut
  • The pentasaccharide: Fondaparinux- at a dose of 5 mg for body weight <50 kg, 7.5 mg for 50-100 kg, and 10 mg for >100 kg, once daily

Make sure to monitor platelet counts regardless of agent chosen.

 

 

References

Konstantinides. Acute pulmonary embolism revisited. Heart. June 2008


University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map